| Dr Steven Bryan Rouse, MD | |
|
1 Guthrie Sq, Sayre, PA 18840-1625 | |
| (570) 888-5858 | |
| Not Available |
| Full Name | Dr Steven Bryan Rouse |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology - Gynecology |
| Location | 1 Guthrie Sq, Sayre, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255304838 | NPI | - | NPPES |
| 00761519 | Medicaid | NY | |
| CC9269 | Other | PA | RR MEDICARE GROUP |
| 0009002150001 | Medicaid | PA | |
| 160049844 | Other | PA | RR MEDICARE PIN |
| GU039794 | Other | PA | PA MEDICARE GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | MD039279L (Pennsylvania) | Primary |
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 154877-1 (New York) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Bryan Rouse, MD 1 Guthrie Sq, Sayre, PA 18840-1625 Ph: (570) 888-5858 | Dr Steven Bryan Rouse, MD 1 Guthrie Sq, Sayre, PA 18840-1625 Ph: (570) 888-5858 |
News Archive
Cell Therapeutics, Inc. announced today that updated phase II study results of OPAXIO in patients with advanced esophageal cancer conducted by the Brown University Oncology Group were published in the February 3, 2011 issue of the American Journal of Clinical Oncology, Dipetrillo, et al., which demonstrate that 38% of the patients receiving OPAXIO in combination with cisplatin and concurrent radiation achieved a pathologic or endoscopic complete response.
Researchers at Case Western Reserve University School of Medicine demonstrated that nitrogen balance, the process of utilizing amino acids and disposing of their toxic byproducts, occurs with a precise 24-hour rhythm - also known as circadian rhythm - in mammals. Disruption of this cycle has a direct impact on survival of organisms, and may predispose one to life altering diseases including diabetes and cardiovascular disease.
Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. today announced the U.S. launch of VERTEX SELECT CHROMALOY Plus Rods.
TSO3 Inc. ("TSO3"), an innovator of low temperature sterilization technology using ozone for medical devices in healthcare settings, today announced that Health Canada has approved the STERIZONE(R) 125L+ Sterilizer for sale in Canada.
A study investigated the comparative efficacy of neutralizing monoclonal antibodies against SARS-CoV-2.
› Verified 5 days ago
Barbara L Wiseman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Square, Sayre, PA 18840 Phone: 570-887-3982 Fax: 607-625-5879 | |
Dr. Russell Eugene Rees, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 Fax: 570-887-2904 | |
Dr. Richard R Lubell, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 Fax: 570-887-2904 | |
Jay K Mehta, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-887-2530 Fax: 570-887-2904 | |
Dr. Elizabeth Gordon, D.O Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Obgyn, Sayre, PA 18840 Phone: 570-888-5858 | |
Samuel Saleeb, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-887-2530 Fax: 570-887-2904 |